Search page

Resources
Resources
All the important scientific output EAACI produces throughout the year
- Guidelines
  Evidence-based recommendations for your clinical practice on a variety of topics
- Position Papers
  The output of our Task Forces, Sections, Interest Groups and Working Groups
- Consensus Documents
  Result of the work of expert panels summarising current knowledge and guidelines on a topic
- Task Forces
  Teams that deal with specific topics that are relevant, controversial or new in the field
- EAACI Journals
  Access to our official Journals published by Wiley
- Covid-19 Resources
  New research and knowledge on the COVID-19 pandemic to better serve you and your patients
Past Events
Past Events
All the important presentations and posters of our past expert events
- Annual Congress
  Our flagship event world’s largest congress specialising in the field of allergy and clinical immunology
- Focused Meetings
  Our mid-size events address key areas in the field of allergy and provide knowledge-sharing and training
- Master Classes
  Workshops that cover both clinical and transitional topics of a specific field with the aim to dive deeper
- Allergy & Winter Schools
  These training courses focus on a specific topic within allergy and are built to offer a solid foundation in this area
Industry Content
Industry Content
Our industry partners provide you with the necessary data on products and resources to facilitate your daily practice
- Sponsored Symposia
  Symposia and workshops that offer relevant data on up-to-date scientific information and developments from the Industry
- Learning Modules
  Familiarise yourself with a variety of topics, and consolidate your learning by taking assessments after each module
Education
Education
Gain CME accreditation through specific modules offered in this section, explore the Knowledge Exam and books that will assist in your learning journey
- Educational Courses
  Complete the assessments within each topical module, gain CME credits and a deep understanding of the subject of your choice
- EAACI Webinars
  Learn more about a specific topic in the field through interactive webinars with an excellent panel of speakers
- Knowledge Exam
  The exam is based on revised questions prepared by EAACI Task Force members and members from different European centres
- Books
  Discover more on a specific topic on allergy and clinical immunology and expand your knowledge through our books
Community
Community
This section’s aim is to facilitate networking among our many members. Our community fosters best practices and knowledge-sharing worldwide
- People Directory
  Provides you with contact details to get in touch with like-minded peers
- Chat
  Directly chat with colleagues and friends and create long-lasting partnerships
- News
  What is going on in EAACI? Find out our latest news on this page
- Interviews
  Watch our one-on-one interviews with our experts to find out more about a topic
- Podcasts
  Explore the subject of your choice through our audio podcasts with our experts
- Public Outreach
  Evidence-based recommendations that have the aim to tackle the burden of allergy in Europe
Patients
Patients
Recommendations on diagnosis, treatment and management, in addition to useful interactive courses and a forum for open discussion between peers
- Patient Organisations
  Patient Organisations, that communicate directly with patients affected by allergic diseases and asthma worldwide
- Patient Resources
  A series of interactive resources that may assist and inform you and your loved ones living with allergic diseases and asthma
- Patient Forum
  Directly communicate with peers to share your experiences, learnings and your journey with allergic diseases and asthma

Clear all

(335 Results)

Filter

What are you looking for?

Category
- adolescent
- asthma
- EAACI position paper
- anaphylaxis
- COVID-19
- consensus document
- biologicals
- hypersensitivity
- transitional
- allergy asthma and a sport
- allergy diagnosis
- allied health and primary care
- allergen immunotherapy (AIT)
- food allergy
- food allergy and anaphylaxis
- drug allergy
- pediatrics
- basic immunology
- dermatology
- ENT
- environmental allergy and climate change
- immune deficiencies and autoimmunity
- AllergoOncology
- epidemiology
- systems medicine
- insect venom hypersensitivities
- immunomodulation and nutrition
- eosinophilic esophagitis (EoE)
- microbiome
- comparative veterinary allergology
- mastocytosis and mast cells
Type
- Position Papers
- Covid-19
- Annual Congress
- Master Classes
- Allergy & Winter School
- Event Resources
- Sponsored Symposia
Year
- 2018
- 2019
- 2020
- 2021
- 2022
- 2023
Keywords
- allergy and environment
- Allergy diagnosis
- master class
- COVID-19
- DGAKI
- asthma control
- Beijing
- COVID‐19
- self‐management
- criticalillness
- riskfactors
- SARS-CoV-2
- severity
- containment
- COVID19
- hygiene
- outbreak
- pediatric
- angiotensin-convertingenzymeII
- chronicrhinosinusitis
- coronavirusdisease2019
- inferiorturbinate
- interferon
- sinus
- chronicurticaria
- cyclosporine
- omalizumab
- pandemic
- treatment
- UCARE
- aerobiology
- COVID
- SARS-CoV
- Asthma
- COVID-19 lockdown
- exacerbations
- lung function test
- peak expiratory flow
- angiotensin-convertingenzyme2
- cabbage
- diet
- fermentedvegetable
- kimchi
- Lactobacillus
- sulforaphane
- Antibodies
- glycans
- immunoglobulinM
- pneumonia
- prediction
- protection
- Infections
- Vaccines
- allergy
- Anaphylaxis
- vaccine
- immunecomplex
- molecularinteractionassay
- protectiveantibodies
- allergic rhinitis
- common cold
- cough
- smell
- italy
- SANI
- severe asthma
- mumps‐measles‐rubella
- antibody-dependentenhancement
- Kawasakisyndrome
- multisysteminflammatorysyndrome
- Childhood allergies
- immunodeficiencies
- pediatrics
- BTK
- immunoglobulins
- Xlinkedagammaglobulinemia
- BNT162b2
- mRNA
- severeallergicreactions
- Virus
- allergic diseases
- bronchial asthma
- Polish Allergology Society
- Biologics
- CRSwNP
- atopic dermatitis
- adolescent
- transition
- young adult
- Adrenaline
- COVID-19 vaccines
- older (adults/people)
- altitude
- climate
- environment
- pulmonary rehabilitation
- biologicals
- desensitization
- Drug hypersensitivity
- hypersensitivity reactions
- monoclonal Abs
- Adolescents
- survey
- young adults
- exercise
- immunology
- physiology
- sport
- food allergy
- noninvasive diagnosis
- allergy diagnosis
- allergy treatment
- Education
- learning methods
- primary care
- allergen
- immunotherapy
- mRNA vaccines
- severe allergic reactions
- Nutrition
- Chronic rhinosinusitis
- Chronic rhinosinusitis with nasal polyposis (CRSwNP)
- eaaci hybrid congress 2022
- Medthority CME supported by Novartis
- dbv technologies
- eaaci hybrid congress 2021
- Peanut allergy
- phenotypes
- Sanofi Regeneron
- severe type 2 asthma
- Rhinitis
- Satellite Symposia
- asthma management
- Astrazeneca
- Relegating OCS to last resort: Creating a paradigm shift in asthma management
- allergy therapeutics
- beta-lactoglobulin
- micronutrient
- clinical cases
- Faes Farma
- Menarini Group
- complex world of allergy
- LETI Pharma
- personalized medicine
- HMO
- immune system
- Nestlé Health Science
- chronic spontaneous urticaria
- Novartis
- Hereditary angioedema (HAE)
- patient care
- Takeda
- Asthma treatment
- Biomarkers
- ENT
- C1-INH
- CSL Behring
- hereditary angioedema
- Prophylactic Treatment
- GSK
- severe eisinophilic asthma
- Pharming
- TAKHZYRO
- AIT
- eaaci2021
- Stallergenes Greer
- type 2 inflammation
- Atopic dermatitis
- pediatric atopic dermatitis
- SAM 2021
- ALK
- allergy immunotherapy
- PAAAM 2021
- paediatric awareness
- respiratory allergy
- Cutaneous manifestation
- Dermatology
- Differential diagnosis
- “omics” and systems biology
- Environment and hygiene hypothesis
- epigenetic
- Paediatrics
- Breastfeeding
- Prevention
- airways
- Inflammation
- Allergic contact dermatitis
- Skin
- Allergy treatment
- Asthma treatment
- guidelines
- Pneumology
- Angioedema
- Immunotherapy clinical
- Clinical aspects
- eHealth
- mHealth
- Quality-of-life
- management
- Rapid drug desensitization
- Oral immunotherapy
- eosinophilic fasciitis
- Eosinophils
- Urticaria
- Skin barrier
- Skincare
- Epidemiology
- Microbiome
- Emollient
- Food allergy
- Moisturisers
- Endotypes
- sinusitis
- Transition process
- Epithelial barrier
- Epithelium
- mental health
- Basic and Clinical Immunology Section
- climate change
- Environment and Immunology StandUp Talks
- European parliament
- healthier environment
- Microbial Disease
- New challenges
- scientific career
- StandUp Talks
- WS 2023 Davos
- allergic disease
- Phenotype
- Allergens and epitopes
- component resolved diagnosis
- Immunotherapy and tolerance induction
- Pollen
- primary immunodeficiency
- Air pollution
- COVID-19 pandemic
- antigen presenting cells
- Dendritic cells
- Immune tolerance
- Innate immunity
- patient reported outcome
- sleep pattern
- SoMe
- food labelling
- threshold dose
- Personalized medicine
- Chronic spontaneous urticaria (CSU)
- Barrier
- beta-lactam
- dupilumab
- eosinophil
- Esophagitis
- Virtual care
- Basic mechanisms
- Clinical immunology
- Component resolved diagnosis (CRD)
- Immunologic tests
- Panallergen
- Bovine milk
- Cow's milk
- Patch test
- Machine learning
- Prediction model
- peak expiratory flow (PEF)
- Spirometry
- bacterial lysate
- atopy
- cancer
- Epitome
- Peanut
- adolesent and young adult (AYA)
- Deep learning
- teleHealth
- telemedicine
- Allergic rhinitis (AR)
- Probiotic
- Eldery
- Rhinovirus
- Birch
- House dust mite (HDM)
- Mobile health (mHealth)
- disease burden
- Bioinformatics
- Genetics
- Genome-wide association study (GWAS)
- Pregnancy
- Allergen sequence database
- Venom and insect allergy
- Epicutaneous immunotherapy
- Plane tree
- Pollen forecast
- allegen immunotherapy (AIT)
- Drug allergy
- Abdominal pain
- Interferons
- Immune health
- dietary management
- contraindications
- risk factors
- Outcome measures
- Placebo effect
- polyethylene glycol
- Food-induced anaphylaxis (FIA)
- Gene expression
- Remodelling
- ligelizumab
- immune phenotype
- Atopic dermatitis (AD)
- Fungi
- Azelastine fluticasone
- Platanus hybrida
- Phase-3 study
- Tezepelumab
- Breg cells
- House dust mite
- psychology
- challenge tests
- drug provocation test (dpt)
- Biotin
- IgE
- alpha-gal allergy
- Basophil activation test
- Symptom scale
- Animal models
- Inflammasome
- food protein induced enterocolitis syndrome (FPIES)
- cytokine
- Atopic eosinophilic asthma
- Benralizumab
- Human bronchial smooth muscle cells (BMSC)
- MicroRNA (miRNA)
- Allergic conjunctivitis (AC)
- Environmental exposure chamber (EEC)
- Ocular allergy
- Sublingual
- Acoustic rhinometry
- Challenge tests
- Symptom score
- IL-37b
- Interleukins
- EGR-1
- Egg allergy
- blood eosinophil
- nasal polyps…)
- sinusitis
- ENT (rhinitis
- disease model
- T cells
- allergens and epitopes
- lymphocyte transformation test (LTT)
- asthma exacerbations
- nasal polyps…)
- Thunderstorm asthma
- probiotics
- conjunctivitis
- Rhinoconjunctivitis
- yellow fever
- Dysbiosis
- Inflammatory bowel disease (IBD)
- Transcriptome
- Antolimab
- Terriers
- Avapritinib
- Mast cells Dermatology
- Systemic mastocytosis (SM)
Author
- Alviani, C.
- Gore, C.
- Vazquez-Ortiz, M.
- Agache, I.
- Blain, H.
- Bousquet, J.
- Cogo, A.
- Drijver-Messelink, M.T.
- Fieten, K.B.
- Akdis, C.A.
- Jutel, M.
- Alvarez-Cuesta, E.
- Bavbek, S.
- Pagani, M.
- Dunn Galvin, A.
- Khaleva, E.
- Knibb, R.
- Bonini, M.
- Price, O.J.
- Walsted, E.S.
- Baumann, R.
- Untersmayr, E.
- Zissler, U.M.
- Angier, E.
- Cabrera, M.
- Ryan, D.
- Palomares, O.
- Torres, M.J.
- Hagemann, J.
- Onorato, G.L.
- Klimek, L.
- Aberer, W.
- Dörr, T.
- Zuberbier, T.
- Eiwegger, T.
- Ollert, M.
- Sokolowska, M.
- Vultaggio, A.
- Fernández-Rivas, M.
- Lack, G.
- Santos, A.
- Blümchen, K.
- Brough, H.A.
- Eigenmann, P.
- Muraro, A.
- O'B Hourihane, J.
- Busse, W.
- Heffler, E.
- Korn, S.
- Bosnic-Anticevich, S.
- Canonica, G.W.
- Holmes, S.
- Maspero, J.
- Roth-Walter, F.
- Braido, F.
- Rodríguez Del Río, P.
- Rouger, M.
- Carnés, J.
- Delgado, L.
- Mösges, R.
- Shamji, M.H.
- Heine, R.
- Nutten, S.
- O’Mahony, L.
- Vandenplas, Y.
- Kocatürk, E.
- Maurer, M.
- Savic, S.
- Betschel, S.
- Sala Cunill, A.
- Sevciovic Grumach, A.
- Bachert, C.
- Howarth, P.
- Beck, L.
- Biedermann, T.
- Cimbollek, S.
- Levy, D.
- Magerl, M.
- Chandra, A.
- Sediva, A.
- Jesenak, M.
- Kessel, A.
- Recke, A.
- Mullol, J.
- Boguniewciz, M.
- Paller, A.
- Siegfried, E.
- Bansal, P.
- Mack, D.
- Roberts, G.
- Doña, I.
- Melén, E.
- Mukherjee, M.
- Goossens, A.
- Genuneit, J.
- Pérez de Llano, L.
- Jacobsen, L.
- Perkin, M.
- Castells, M.
- Kelleher, M.
- Ferrando anaut, P.
- Boyle, R.
- Peters, A.
- DunnGalvin, A.
- Fokkens, W.
- Pietikäinen, S.
- Prunicki, M.
- Barber, D.
- Chan, E.
- Gennery, A.
- Chung, K.
- del Giacco, S.
- Benito Villalvilla, C.
- Torun, E.
- Diwakar, L.
- Popescu, F.
- Kuna, P.
- Asero, R.
- Knol, E.
- Brockow, K.
- Chehade, M.
- Dramburg, S.
- Kleine-Tebbe, J.
- van Neerven, R.
- Verhasselt, V.
- Rustemeyer, T.
- Kothalawala, D.
- Solinski, M.
- Gupta, R.
- Emeryk, A.
- Jensen-Jarolim, E.
- Campbell, D.
- Szefler, S.
- Besednjak-Kocijancic, L.
- Wardzynska, A.
- Myszkowska, D.
- Pfaar, O.
- Braunstahl, G.
- Kucharczyk, A.
- Rossi, A.
- Reginald, K.
- Goodman, R.
- Thirumala Krishna, M.
- Deshpande, D.
- Antunes, C.
- Tham, E.
- Kuziemski, K.
- Johnston, S.
- Van Bilsen, J.
- Skypala, I.J.
- Sturm, G.
- Mahler, V.
- Moya, B.
- Sabouraud, D.
- Kozlik, P.
- Alvaro-Lozano, M.
- Gamez, C.
- Schmid, B.
- Van Weissenbruch, R.
- Corren, J.
- Akdis, M.
- Marcoux, D.
- Gerth van Wijk, R.
- Cunha, I.
- Scheib, N.
- Eberlein, B.
- Arkhipova, S.
- Lee, Y.
- Bernstein, J.
- Szymanski, L.
- Jackson, D.
- Rodrigo-Muñoz, J.
- Salapatek, A.
- Song, K.
- Eguiluz-Gracia, I.
- Wong, C.
- Van Dijk, Y.
- Suprun, M.
- Arasi, S.
- Pavord, I.
- Fiocchi, A.
- Rothenberg, M.
- Feleszko, W.
- Hirahara, K.
- Fernández Santamaría, R.
- Pavlova, K.
- Thien, F.
- Kang, M.
- Emson, C.
- Achten, R.
- Kosowska, A.
- Kleuskens, M.
- Wechsler, M.
- Walter, J.
- Marrs, T.
- Hamilton, J.
- Leonardi, A.
- Rostaher, A.
- Hartmann, K.
- Larenas-linnemann, D.